<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36980297</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>21</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Brain Vascular Health in ALS Is Mediated through Motor Cortex Microvascular Integrity.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">957</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12060957</ELocationID><Abstract><AbstractText>Brain vascular health appears to be critical for preventing the development of amyotrophic lateral sclerosis (ALS) and slowing its progression. ALS patients often demonstrate cardiovascular risk factors and commonly suffer from cerebrovascular disease, with evidence of pathological alterations in their small cerebral blood vessels. Impaired vascular brain health has detrimental effects on motor neurons: vascular endothelial growth factor levels are lowered in ALS, which can compromise endothelial cell formation and the integrity of the blood-brain barrier. Increased turnover of neurovascular unit cells precedes their senescence, which, together with pericyte alterations, further fosters the failure of toxic metabolite removal. We here provide a comprehensive overview of the pathogenesis of impaired brain vascular health in ALS and how novel magnetic resonance imaging techniques can aid its detection. In particular, we discuss vascular patterns of blood supply to the motor cortex with the number of branches from the anterior and middle cerebral arteries acting as a novel marker of resistance and resilience against downstream effects of vascular risk and events in ALS. We outline how certain interventions adapted to patient needs and capabilities have the potential to mechanistically target the brain microvasculature towards favorable motor cortex blood supply patterns. Through this strategy, we aim to guide novel approaches to ALS management and a better understanding of ALS pathophysiology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schreiber</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4439-4374</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Otto von Guericke University Magdeburg, Medical Faculty, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Behavioral Brain Sciences (CBBS), 39106 Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernal</LastName><ForeName>Jose</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3167-5134</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Otto von Guericke University Magdeburg, Medical Faculty, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arndt</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-0517-6473</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Otto von Guericke University Magdeburg, Medical Faculty, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schreiber</LastName><ForeName>Frank</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-9484-8613</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Otto von Guericke University Magdeburg, Medical Faculty, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine/Cardiology and Angiology, Otto von Guericke University Magdeburg, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morton</LastName><ForeName>Lorena</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3957-3848</Identifier><AffiliationInfo><Affiliation>Institute of Inflammation and Neurodegeneration, Otto von Guericke University Magdeburg, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braun-Dullaeus</LastName><ForeName>R&#xfc;diger Christian</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Cardiology and Angiology, Otto von Guericke University Magdeburg, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vald&#xe9;s-Hern&#xe1;ndez</LastName><ForeName>Maria Del Carmen</ForeName><Initials>MDC</Initials><Identifier Source="ORCID">0000-0003-2771-6546</Identifier><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, The University of Edinburgh, UK Dementia Research Institute Centre, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, The University of Edinburgh, UK Dementia Research Institute Centre, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wardlaw</LastName><ForeName>Joanna Marguerite</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-9812-6642</Identifier><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, The University of Edinburgh, UK Dementia Research Institute Centre, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meuth</LastName><ForeName>Sven G&#xfc;nther</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical Faculty, Heinrich Heine University D&#xfc;sseldorf, 40225 D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mietzner</LastName><ForeName>Grazia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, Otto von Guericke University Magdeburg, Medical Faculty, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vielhaber</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Otto von Guericke University Magdeburg, Medical Faculty, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Behavioral Brain Sciences (CBBS), 39106 Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunay</LastName><ForeName>Ildiko Rita</ForeName><Initials>IR</Initials><AffiliationInfo><Affiliation>Center for Behavioral Brain Sciences (CBBS), 39106 Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Inflammation and Neurodegeneration, Otto von Guericke University Magdeburg, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dityatev</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0472-0553</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Behavioral Brain Sciences (CBBS), 39106 Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, Otto von Guericke University, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jandke</LastName><ForeName>Solveig</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9103-7276</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Otto von Guericke University Magdeburg, Medical Faculty, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattern</LastName><ForeName>Hendrik</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-5740-4522</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Behavioral Brain Sciences (CBBS), 39106 Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Magnetic Resonance, Faculty of Natural Sciences, Otto von Guericke University Magdeburg, 39120 Magdeburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="Y">Motor Cortex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042461" MajorTopicYN="N">Vascular Endothelial Growth Factor A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="N">Blood-Brain Barrier</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">exerkines</Keyword><Keyword MajorTopicYN="N">motor cortex</Keyword><Keyword MajorTopicYN="N">pericytes</Keyword><Keyword MajorTopicYN="N">vascular supply</Keyword></KeywordList><CoiStatement>A.D. is Editor-in-Chief of the Cell Microenvironment section of Cells.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36980297</ArticleId><ArticleId IdType="pmc">PMC10047140</ArticleId><ArticleId IdType="doi">10.3390/cells12060957</ArticleId><ArticleId IdType="pii">cells12060957</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Braak H., Brettschneider J., Ludolph A.C., Lee V.M., Trojanowski J.Q., Del Tredici K. Amyotrophic lateral sclerosis--a model of corticofugal axonal spread. Nat. Rev. Neurol. 2013;9:708&#x2013;714. doi: 10.1038/nrneurol.2013.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.221</ArticleId><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Asakawa K., Handa H., Kawakami K. Multi-phaseted problems of TDP-43 in selective neuronal vulnerability in ALS. Cell. Mol. Life Sci. 2021;78:4453&#x2013;4465. doi: 10.1007/s00018-021-03792-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-021-03792-z</ArticleId><ArticleId IdType="pmc">PMC8195926</ArticleId><ArticleId IdType="pubmed">33709256</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J., Paul P., Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology. 2007;68:1571&#x2013;1575. doi: 10.1212/01.wnl.0000260965.20021.47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000260965.20021.47</ArticleId><ArticleId IdType="pubmed">17485643</ArticleId></ArticleIdList></Reference><Reference><Citation>Walhout R., Verstraete E., van den Heuvel M.P., Veldink J.H., van den Berg L.H. Patterns of symptom development in patients with motor neuron disease. Amyotroph. Lateral Scler. Frontotemporal Degener. 2018;19:21&#x2013;28. doi: 10.1080/21678421.2017.1386688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1386688</ArticleId><ArticleId IdType="pubmed">29037065</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Del Tredici K., Toledo J.B., Robinson J.L., Irwin D.J., Grossman M., Suh E., van Deerlin V.M., Wood E.M., Baek Y., et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 2013;74:20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur K.C., Calvo A., Price T.R., Geiger J.T., Chi&#xf2; A., Traynor B.J. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat. Commun. 2016;7:12408. doi: 10.1038/ncomms12408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12408</ArticleId><ArticleId IdType="pmc">PMC4987527</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Deng J., Jaffa M., Cudkowicz M.E., Wills A.-M. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve. 2011;44:20&#x2013;24. doi: 10.1002/mus.22114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22114</ArticleId><ArticleId IdType="pmc">PMC4441750</ArticleId><ArticleId IdType="pubmed">21607987</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H.-J., Debray T.P.A., Visser A.E., van Eijk R.P.A., Rooney J.P.K., Calvo A., Martin S., McDermott C.J., Thompson A.G., Pinto S., et al. Prognosis for patients with amyotrophic lateral sclerosis: Development and validation of a personalised prediction model. Lancet Neurol. 2018;17:423&#x2013;433. doi: 10.1016/S1474-4422(18)30089-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30089-9</ArticleId><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedlack R.S., Vaughan T., Wicks P., Heywood J., Sinani E., Selsov R., Macklin E.A., Schoenfeld D., Cudkowicz M., Sherman A. How common are ALS plateaus and reversals? Neurology. 2016;86:808&#x2013;812. doi: 10.1212/WNL.0000000000002251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002251</ArticleId><ArticleId IdType="pmc">PMC4793781</ArticleId><ArticleId IdType="pubmed">26658909</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupillo E., Messina P., Logroscino G., Beghi E. Long-term survival in amyotrophic lateral sclerosis: A population-based study. Ann. Neurol. 2014;75:287&#x2013;297. doi: 10.1002/ana.24096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24096</ArticleId><ArticleId IdType="pubmed">24382602</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabeza R., Albert M., Belleville S., Craik F.I.M., Duarte A., Grady C.L., Lindenberger U., Nyberg L., Park D.C., Reuter-Lorenz P.A., et al. Maintenance, reserve and compensation: The cognitive neuroscience of healthy ageing. Nat. Rev. Neurosci. 2018;19:701&#x2013;710. doi: 10.1038/s41583-018-0068-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-018-0068-2</ArticleId><ArticleId IdType="pmc">PMC6472256</ArticleId><ArticleId IdType="pubmed">30305711</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenaza-Urquijo E.M., Vemuri P. Resistance vs resilience to Alzheimer disease: Clarifying terminology for preclinical studies. Neurology. 2018;90:695&#x2013;703. doi: 10.1212/WNL.0000000000005303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005303</ArticleId><ArticleId IdType="pmc">PMC5894932</ArticleId><ArticleId IdType="pubmed">29592885</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber S., Vogel J., Schwimmer H.D., Marks S.M., Schreiber F., Jagust W. Impact of lifestyle dimensions on brain pathology and cognition. Neurobiol. Aging. 2016;40:164&#x2013;172. doi: 10.1016/j.neurobiolaging.2016.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.01.012</ArticleId><ArticleId IdType="pmc">PMC4792130</ArticleId><ArticleId IdType="pubmed">26973116</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe P.A., Garton F.C., Katz M., Wray N.R., Henderson R.D. What do we know about the variability in survival of patients with amyotrophic lateral sclerosis? Expert Rev. Neurother. 2020;20:921&#x2013;941. doi: 10.1080/14737175.2020.1785873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2020.1785873</ArticleId><ArticleId IdType="pubmed">32569484</ArticleId></ArticleIdList></Reference><Reference><Citation>Sever B., Ciftci H., DeMirci H., Sever H., Ocak F., Yulug B., Tateishi H., Tateishi T., Otsuka M., Fujita M., et al. Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2022;23:2400. doi: 10.3390/ijms23052400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23052400</ArticleId><ArticleId IdType="pmc">PMC8910198</ArticleId><ArticleId IdType="pubmed">35269543</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenaza-Urquijo E.M., Przybelski S.A., Lesnick T.L., Graff-Radford J., Machulda M.M., Knopman D.S., Schwarz C.G., Lowe V.J., Mielke M.M., Petersen R.C., et al. The metabolic brain signature of cognitive resilience in the 80+: Beyond Alzheimer pathologies. Brain. 2019;142:1134&#x2013;1147. doi: 10.1093/brain/awz037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz037</ArticleId><ArticleId IdType="pmc">PMC6439329</ArticleId><ArticleId IdType="pubmed">30851100</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumitrescu L., Mahoney E.R., Mukherjee S., Lee M.L., Bush W.S., Engelman C.D., Lu Q., Fardo D.W., Trittschuh E.H., Mez J., et al. Genetic variants and functional pathways associated with resilience to Alzheimer&#x2019;s disease. Brain. 2020;143:2561&#x2013;2575. doi: 10.1093/brain/awaa209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa209</ArticleId><ArticleId IdType="pmc">PMC7447518</ArticleId><ArticleId IdType="pubmed">32844198</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston G., Huntley J., Sommerlad A., Ames D., Ballard C., Banerjee S., Brayne C., Burns A., Cohen-Mansfield J., Cooper C., et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413&#x2013;446. doi: 10.1016/S0140-6736(20)30367-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30367-6</ArticleId><ArticleId IdType="pmc">PMC7392084</ArticleId><ArticleId IdType="pubmed">32738937</ArticleId></ArticleIdList></Reference><Reference><Citation>Palta P., Albert M.S., Gottesman R.F. Heart health meets cognitive health: Evidence on the role of blood pressure. Lancet Neurol. 2021;20:854&#x2013;867. doi: 10.1016/S1474-4422(21)00248-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00248-9</ArticleId><ArticleId IdType="pmc">PMC8605628</ArticleId><ArticleId IdType="pubmed">34536406</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungvari Z., Toth P., Tarantini S., Prodan C.I., Sorond F., Merkely B., Csiszar A. Hypertension-induced cognitive impairment: From pathophysiology to public health. Nat. Rev. Nephrol. 2021;17:639&#x2013;654. doi: 10.1038/s41581-021-00430-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00430-6</ArticleId><ArticleId IdType="pmc">PMC8202227</ArticleId><ArticleId IdType="pubmed">34127835</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters R., Xu Y., Fitzgerald O., Aung H.L., Beckett N., Bulpitt C., Chalmers J., Forette F., Gong J., Harris K., et al. Blood pressure lowering and prevention of dementia: An individual patient data meta-analysis. Eur. Heart J. 2022;43:4980&#x2013;4990. doi: 10.1093/eurheartj/ehac584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac584</ArticleId><ArticleId IdType="pubmed">36282295</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang A.C., Vest R.T., Kern F., Lee D.P., Agam M., Maat C.A., Losada P.M., Chen M.B., Schaum N., Khoury N., et al. A human brain vascular atlas reveals diverse mediators of Alzheimer&#x2019;s risk. Nature. 2022;603:885&#x2013;892. doi: 10.1038/s41586-021-04369-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04369-3</ArticleId><ArticleId IdType="pmc">PMC9635042</ArticleId><ArticleId IdType="pubmed">35165441</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerrits E., Giannini L.A.A., Brouwer N., Melhem S., Seilhean D., Le Ber I., Kamermans A., Kooij G., de Vries H.E., Boddeke E.W.G.M., et al. Neurovascular dysfunction in GRN-associated frontotemporal dementia identified by single-nucleus RNA sequencing of human cerebral cortex. Nat. Neurosci. 2022;25:1034&#x2013;1048. doi: 10.1038/s41593-022-01124-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-022-01124-3</ArticleId><ArticleId IdType="pubmed">35879464</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia F.J., Sun N., Lee H., Godlewski B., Mathys H., Galani K., Zhou B., Jiang X., Ng A.P., Mantero J., et al. Single-cell dissection of the human brain vasculature. Nature. 2022;603:893&#x2013;899. doi: 10.1038/s41586-022-04521-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04521-7</ArticleId><ArticleId IdType="pmc">PMC9680899</ArticleId><ArticleId IdType="pubmed">35158371</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Tada M., Cai Z., Andhey P.S., Swain A., Miller K.R., Gilfillan S., Artyomov M.N., Takao M., Kakita A., et al. Human early-onset dementia caused by DAP12 deficiency reveals a unique signature of dysregulated microglia. Nat. Immunol. 2023;24:545&#x2013;557. doi: 10.1038/s41590-022-01403-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01403-y</ArticleId><ArticleId IdType="pmc">PMC9992145</ArticleId><ArticleId IdType="pubmed">36658241</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg S.M. Vascular Contributions to Brain Health: Cross-Cutting Themes. Stroke. 2022;53:391&#x2013;393. doi: 10.1161/STROKEAHA.121.034921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.121.034921</ArticleId><ArticleId IdType="pubmed">35000428</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuraszkiewicz B., Goszczy&#x144;ska H., Podsiad&#x142;y-Marczykowska T., Piotrkiewicz M., Andersen P., Gromicho M., Grosskreutz J., Ku&#x17a;ma-Kozakiewicz M., Petri S., Stubbendorf B., et al. Potential Preventive Strategies for Amyotrophic Lateral Sclerosis. Front. Neurosci. 2020;14:428. doi: 10.3389/fnins.2020.00428.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00428</ArticleId><ArticleId IdType="pmc">PMC7264408</ArticleId><ArticleId IdType="pubmed">32528241</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman E.L., Goutman S.A., Petri S., Mazzini L., Savelieff M.G., Shaw P.J., Sobue G. Amyotrophic lateral sclerosis. Lancet. 2022;400:1363&#x2013;1380. doi: 10.1016/S0140-6736(22)01272-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01272-7</ArticleId><ArticleId IdType="pubmed">36116464</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman S.A., Hardiman O., Al-Chalabi A., Chi&#xf3; A., Savelieff M.G., Kiernan M.C., Feldman E.L. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21:465&#x2013;479. doi: 10.1016/S1474-4422(21)00414-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00414-2</ArticleId><ArticleId IdType="pmc">PMC9513754</ArticleId><ArticleId IdType="pubmed">35334234</ArticleId></ArticleIdList></Reference><Reference><Citation>Diekmann K., Kuzma-Kozakiewicz M., Piotrkiewicz M., Gromicho M., Grosskreutz J., Andersen P.M., de Carvalho M., Uysal H., Osmanovic A., Schreiber-Katz O., et al. Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group. J. Neurol. 2020;267:2130&#x2013;2141. doi: 10.1007/s00415-020-09799-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09799-z</ArticleId><ArticleId IdType="pubmed">32266542</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu K., Ji H., Hu N. Cardiovascular comorbidities in amyotrophic lateral sclerosis: A systematic review. J. Clin. Neurosci. 2022;96:43&#x2013;49. doi: 10.1016/j.jocn.2021.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2021.12.021</ArticleId><ArticleId IdType="pubmed">34974247</ArticleId></ArticleIdList></Reference><Reference><Citation>Julian T.H., Boddy S., Islam M., Kurz J., Whittaker K.J., Moll T., Harvey C., Zhang S., Snyder M.P., McDermott C., et al. A review of Mendelian randomization in amyotrophic lateral sclerosis. Brain. 2022;145:832&#x2013;842. doi: 10.1093/brain/awab420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab420</ArticleId><ArticleId IdType="pmc">PMC9050546</ArticleId><ArticleId IdType="pubmed">34791088</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres-Ciga S., Noyce A.J., Hemani G., Nicolas A., Calvo A., Mora G., Tienari P.J., Stone D.J., Nalls M.A., Singleton A.B., et al. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann. Neurol. 2019;85:470&#x2013;481. doi: 10.1002/ana.25431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25431</ArticleId><ArticleId IdType="pmc">PMC6450729</ArticleId><ArticleId IdType="pubmed">30723964</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Ou R., Wei Q., Shang H. Shared genetic links between amyotrophic lateral sclerosis and obesity-related traits: A genome-wide association study. Neurobiol. Aging. 2021;102:211.e1&#x2013;211.e9. doi: 10.1016/j.neurobiolaging.2021.01.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2021.01.023</ArticleId><ArticleId IdType="pubmed">33640203</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J., Ferri L., Fasano A., Zucchi E., Fini N., Moglia C., Lunetta C., Marinou K., Ticozzi N., Drago Ferrante G., et al. Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis. Eur. J. Neurol. 2018;25:861&#x2013;868. doi: 10.1111/ene.13620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13620</ArticleId><ArticleId IdType="pubmed">29512869</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu N., Ji H. Medications on hypertension, hyperlipidemia, diabetes, and risk of amyotrophic lateral sclerosis: A systematic review and meta-analysis. Neurol. Sci. 2022;43:5189&#x2013;5199. doi: 10.1007/s10072-022-06131-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-022-06131-7</ArticleId><ArticleId IdType="pubmed">35616813</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelhak A., H&#xfc;bers A., B&#xf6;hm K., Ludolph A.C., Kassubek J., Pinkhardt E.H. In vivo assessment of retinal vessel pathology in amyotrophic lateral sclerosis. J. Neurol. 2018;265:949&#x2013;953. doi: 10.1007/s00415-018-8787-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8787-x</ArticleId><ArticleId IdType="pubmed">29464376</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley A.F., Bossen E.H. Skeletal muscle microvasculature in the diagnosis of neuromuscular disease. J. Neuropathol. Exp. Neurol. 2013;72:906&#x2013;918. doi: 10.1097/NEN.0b013e3182a7f0b8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3182a7f0b8</ArticleId><ArticleId IdType="pubmed">24042201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolde G., Bachus R., Ludolph A.C. Skin involvement in amyotrophic lateral sclerosis. Lancet. 1996;347:1226&#x2013;1227. doi: 10.1016/S0140-6736(96)90737-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)90737-0</ArticleId><ArticleId IdType="pubmed">8622453</ArticleId></ArticleIdList></Reference><Reference><Citation>Saul J., Hutchins E., Reiman R., Saul M., Ostrow L.W., Harris B.T., van Keuren-Jensen K., Bowser R., Bakkar N. Global alterations to the choroid plexus blood-CSF barrier in amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2020;8:92. doi: 10.1186/s40478-020-00968-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00968-9</ArticleId><ArticleId IdType="pmc">PMC7318439</ArticleId><ArticleId IdType="pubmed">32586411</ArticleId></ArticleIdList></Reference><Reference><Citation>Coon E.A., Castillo A.M., Lesnick T.G., Raghavan S., Mielke M.M., Reid R.I., Windham B.G., Petersen R.C., Jack C.R., Graff-Radford J., et al. Blood pressure changes impact corticospinal integrity and downstream gait and balance control. Neurobiol. Aging. 2022;120:60&#x2013;67. doi: 10.1016/j.neurobiolaging.2022.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2022.08.011</ArticleId><ArticleId IdType="pmc">PMC9613619</ArticleId><ArticleId IdType="pubmed">36122540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota M., Iijima M., Shirai Y., Toi S., Kitagawa K. Association Between Cerebral Small Vessel Disease and Central Motor Conduction Time in Patients with Vascular Risk. J. Stroke Cerebrovasc. Dis. 2019;28:2343&#x2013;2350. doi: 10.1016/j.jstrokecerebrovasdis.2019.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2019.05.030</ArticleId><ArticleId IdType="pubmed">31208821</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferro D.A., Mutsaerts H.J., Hilal S., Kuijf H.J., Petersen E.T., Petr J., van Veluw S.J., Venketasubramanian N., Yeow T.B., Biessels G.J., et al. Cortical microinfarcts in memory clinic patients are associated with reduced cerebral perfusion. J. Cereb. Blood Flow Metab. 2020;40:1869&#x2013;1878. doi: 10.1177/0271678X19877403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X19877403</ArticleId><ArticleId IdType="pmc">PMC7430096</ArticleId><ArticleId IdType="pubmed">31558107</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmazer-Hanke D., Mayer T., M&#xfc;ller H.-P., Neugebauer H., Abaei A., Scheuerle A., Weis J., Forsberg K.M.E., Althaus K., Meier J., et al. Histological correlates of postmortem ultra-high-resolution single-section MRI in cortical cerebral microinfarcts. Acta Neuropathol. Commun. 2020;8:33. doi: 10.1186/s40478-020-00900-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00900-1</ArticleId><ArticleId IdType="pmc">PMC7071593</ArticleId><ArticleId IdType="pubmed">32169123</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones J.D., Castanho P., Bazira P., Sanders K. Anatomical variations of the circle of Willis and their prevalence, with a focus on the posterior communicating artery: A literature review and meta-analysis. Clin. Anat. 2021;34:978&#x2013;990. doi: 10.1002/ca.23662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ca.23662</ArticleId><ArticleId IdType="pubmed">32713011</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdem A., Ya&#x15f;argil G., Roth P. Microsurgical anatomy of the hippocampal arteries. J. Neurosurg. 1993;79:256&#x2013;265. doi: 10.3171/jns.1993.79.2.0256.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/jns.1993.79.2.0256</ArticleId><ArticleId IdType="pubmed">8331410</ArticleId></ArticleIdList></Reference><Reference><Citation>Akashi T., Taoka T., Ochi T., Miyasaka T., Wada T., Sakamoto M., Takewa M., Kichikawa K. Branching pattern of lenticulostriate arteries observed by MR angiography at 3.0 T. Jpn. J. Radiol. 2012;30:331&#x2013;335. doi: 10.1007/s11604-012-0058-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11604-012-0058-7</ArticleId><ArticleId IdType="pubmed">22350636</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C., Yuan C., Li R., Wang W., Li C., Zhao X. Association Between Incomplete Circle of Willis and Carotid Vulnerable Atherosclerotic Plaques. Arterioscler. Thromb. Vasc. Biol. 2018;38:2744&#x2013;2749. doi: 10.1161/ATVBAHA.118.311797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.118.311797</ArticleId><ArticleId IdType="pubmed">30354232</ArticleId></ArticleIdList></Reference><Reference><Citation>Perosa V., Priester A., Ziegler G., Cardenas-Blanco A., Dobisch L., Spallazzi M., Assmann A., Maass A., Speck O., Oltmer J., et al. Hippocampal vascular reserve associated with cognitive performance and hippocampal volume. Brain. 2020;143:622&#x2013;634. doi: 10.1093/brain/awz383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz383</ArticleId><ArticleId IdType="pmc">PMC7009470</ArticleId><ArticleId IdType="pubmed">31994699</ArticleId></ArticleIdList></Reference><Reference><Citation>Perosa V., D&#xfc;zel E., Schreiber S. Reply: Heterogeneity of the circle of Willis and its implication in hippocampal perfusion. Brain. 2020;143:e59. doi: 10.1093/brain/awaa170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa170</ArticleId><ArticleId IdType="pubmed">32594105</ArticleId></ArticleIdList></Reference><Reference><Citation>Vockert N., Perosa V., Ziegler G., Schreiber F., Priester A., Spallazzi M., Garcia-Garcia B., Aruci M., Mattern H., Haghikia A., et al. Hippocampal vascularization patterns exert local and distant effects on brain structure but not vascular pathology in old age. Brain Commun. 2021;3:fcab127. doi: 10.1093/braincomms/fcab127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab127</ArticleId><ArticleId IdType="pmc">PMC8249103</ArticleId><ArticleId IdType="pubmed">34222874</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M.P., Brott T.G., Liebeskind D.S., Meschia J.F., Sam K., Gottesman R.F. Collateral Recruitment Is Impaired by Cerebral Small Vessel Disease. Stroke. 2020;51:1404&#x2013;1410. doi: 10.1161/STROKEAHA.119.027661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.119.027661</ArticleId><ArticleId IdType="pubmed">32248770</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M., Wu Q., Cheng Y., Zhang S., Tao W., Zhang S., Wang D., Liu M., Wu B. Circle of Willis Morphology in Primary Intracerebral Hemorrhage. Transl. Stroke Res. 2022;13:736&#x2013;744. doi: 10.1007/s12975-022-00997-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12975-022-00997-7</ArticleId><ArticleId IdType="pmc">PMC9391241</ArticleId><ArticleId IdType="pubmed">35184272</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugur H.C., Kahilogullari G., Coscarella E., Unlu A., Tekdemir I., Morcos J.J., Elhan A., Baskaya M.K. Arterial vascularization of primary motor cortex (precentral gyrus) Surg. Neurol. 2005;64((Suppl 2)):S48&#x2013;S52. doi: 10.1016/j.surneu.2005.07.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surneu.2005.07.049</ArticleId><ArticleId IdType="pubmed">16256841</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid F., Conti G., Jenny P., Weber B. The severity of microstrokes depends on local vascular topology and baseline perfusion. Elife. 2021;10:e60208. doi: 10.7554/eLife.60208.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.60208</ArticleId><ArticleId IdType="pmc">PMC8421069</ArticleId><ArticleId IdType="pubmed">34003107</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubart A., Benbenishty A., Har-Gil H., Laufer H., Gdalyahu A., Assaf Y., Blinder P. Single Cortical Microinfarcts Lead to Widespread Microglia/Macrophage Migration Along the White Matter. Cereb. Cortex. 2021;31:248&#x2013;266. doi: 10.1093/cercor/bhaa223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhaa223</ArticleId><ArticleId IdType="pubmed">32954425</ArticleId></ArticleIdList></Reference><Reference><Citation>da Costa C.C.P., de Lima N.S., da Cruz Pereira Bento D., da Silva Santos R., da Silva Reis A.A. A strong association between VEGF-A rs28357093 and amyotrophic lateral sclerosis: A brazilian genetic study. Mol. Biol. Rep. 2022;49:9129&#x2013;9133. doi: 10.1007/s11033-022-07647-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-022-07647-z</ArticleId><ArticleId IdType="pubmed">35733060</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambrechts D., Storkebaum E., Morimoto M., Del-Favero J., Desmet F., Marklund S.L., Wyns S., Thijs V., Andersson J., van Marion I., et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 2003;34:383&#x2013;394. doi: 10.1038/ng1211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1211</ArticleId><ArticleId IdType="pubmed">12847526</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockington A., Wharton S.B., Fernando M., Gelsthorpe C.H., Baxter L., Ince P.G., Lewis C.E., Shaw P.J. Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2006;65:26&#x2013;36. doi: 10.1097/01.jnen.0000196134.51217.74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000196134.51217.74</ArticleId><ArticleId IdType="pubmed">16410746</ArticleId></ArticleIdList></Reference><Reference><Citation>Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., van Dorpe J., Hellings P., Gorselink M., Heymans S., et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 2001;28:131&#x2013;138. doi: 10.1038/88842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/88842</ArticleId><ArticleId IdType="pubmed">11381259</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva-Hucha S., Pastor A.M., Morcuende S. Neuroprotective Effect of Vascular Endothelial Growth Factor on Motoneurons of the Oculomotor System. Int. J. Mol. Sci. 2021;22:814. doi: 10.3390/ijms22020814.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22020814</ArticleId><ArticleId IdType="pmc">PMC7830098</ArticleId><ArticleId IdType="pubmed">33467517</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzouz M., Ralph G.S., Storkebaum E., Walmsley L.E., Mitrophanous K.A., Kingsman S.M., Carmeliet P., Mazarakis N.D. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature. 2004;429:413&#x2013;417. doi: 10.1038/nature02544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02544</ArticleId><ArticleId IdType="pubmed">15164063</ArticleId></ArticleIdList></Reference><Reference><Citation>Storkebaum E., Lambrechts D., Dewerchin M., Moreno-Murciano M.-P., Appelmans S., Oh H., van Damme P., Rutten B., Man W.Y., de Mol M., et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci. 2005;8:85&#x2013;92. doi: 10.1038/nn1360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1360</ArticleId><ArticleId IdType="pubmed">15568021</ArticleId></ArticleIdList></Reference><Reference><Citation>van Damme P., Tilkin P., Mercer K.J., Terryn J., D&#x2019;Hondt A., Herne N., Tousseyn T., Claeys K.G., Thal D.R., Zachrisson O., et al. Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I study. Brain Commun. 2020;2:fcaa160. doi: 10.1093/braincomms/fcaa160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa160</ArticleId><ArticleId IdType="pmc">PMC8099230</ArticleId><ArticleId IdType="pubmed">33977260</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S., Hernandez-Ontiveros D.G., Rodrigues M.C.O., Haller E., Frisina-Deyo A., Mirtyl S., Sallot S., Saporta S., Borlongan C.V., Sanberg P.R. Impaired blood-brain/spinal cord barrier in ALS patients. Brain Res. 2012;1469:114&#x2013;128. doi: 10.1016/j.brainres.2012.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.05.056</ArticleId><ArticleId IdType="pubmed">22750125</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler E.A., Sengillo J.D., Sullivan J.S., Henkel J.S., Appel S.H., Zlokovic B.V. Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125:111&#x2013;120. doi: 10.1007/s00401-012-1039-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1039-8</ArticleId><ArticleId IdType="pmc">PMC3535352</ArticleId><ArticleId IdType="pubmed">22941226</ArticleId></ArticleIdList></Reference><Reference><Citation>Rustenhoven J., Jansson D., Smyth L.C., Dragunow M. Brain Pericytes As Mediators of Neuroinflammation. Trends Pharmacol. Sci. 2017;38:291&#x2013;304. doi: 10.1016/j.tips.2016.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2016.12.001</ArticleId><ArticleId IdType="pubmed">28017362</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J., Korte N., Nortley R., Sethi H., Tang Y., Attwell D. Targeting pericytes for therapeutic approaches to neurological disorders. Acta Neuropathol. 2018;136:507&#x2013;523. doi: 10.1007/s00401-018-1893-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1893-0</ArticleId><ArticleId IdType="pmc">PMC6132947</ArticleId><ArticleId IdType="pubmed">30097696</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S. Alterations of the blood-spinal cord barrier in sporadic amyotrophic lateral sclerosis. Neuropathology. 2015;35:518&#x2013;528. doi: 10.1111/neup.12221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12221</ArticleId><ArticleId IdType="pubmed">26242689</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamadera M., Fujimura H., Inoue K., Toyooka K., Mori C., Hirano H., Sakoda S. Microvascular disturbance with decreased pericyte coverage is prominent in the ventral horn of patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 2015;16:393&#x2013;401. doi: 10.3109/21678421.2015.1011663.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1011663</ArticleId><ArticleId IdType="pubmed">25740316</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Z., Deane R., Ali Z., Parisi M., Shapovalov Y., O&#x2019;Banion M.K., Stojanovic K., Sagare A., Boillee S., Cleveland D.W., et al. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat. Neurosci. 2008;11:420&#x2013;422. doi: 10.1038/nn2073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2073</ArticleId><ArticleId IdType="pmc">PMC2895310</ArticleId><ArticleId IdType="pubmed">18344992</ArticleId></ArticleIdList></Reference><Reference><Citation>Coatti G.C., Frangini M., Valadares M.C., Gomes J.P., Lima N.O., Cava&#xe7;ana N., Assoni A.F., Pelatti M.V., Birbrair A., de Lima A.C.P., et al. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient. Stem Cell Rev. Rep. 2017;13:686&#x2013;698. doi: 10.1007/s12015-017-9752-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-017-9752-2</ArticleId><ArticleId IdType="pubmed">28710685</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe5;nberg A., Skene N., Sanders F., Trusohamn M., Remnest&#xe5;l J., Szczepi&#x144;ska A., Aksoylu I.S., L&#xf6;nnerberg P., Ebarasi L., Wouters S., et al. Altered perivascular fibroblast activity precedes ALS disease onset. Nat. Med. 2021;27:640&#x2013;646. doi: 10.1038/s41591-021-01295-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01295-9</ArticleId><ArticleId IdType="pmc">PMC7613336</ArticleId><ArticleId IdType="pubmed">33859435</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Xie Y.-Z., Liu Y.-S. Accelerated aging-related transcriptome alterations in neurovascular unit cells in the brain of Alzheimer&#x2019;s disease. Front. Aging Neurosci. 2022;14:949074. doi: 10.3389/fnagi.2022.949074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.949074</ArticleId><ArticleId IdType="pmc">PMC9435434</ArticleId><ArticleId IdType="pubmed">36062157</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelke C., Schroeter C.B., Pawlitzki M., Meuth S.G., Ruck T. Cellular senescence in neuroinflammatory disease: New therapies for old cells? Trends Mol. Med. 2022;28:850&#x2013;863. doi: 10.1016/j.molmed.2022.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2022.07.003</ArticleId><ArticleId IdType="pubmed">35965205</ArticleId></ArticleIdList></Reference><Reference><Citation>Polsky L.R., Rentscher K.E., Carroll J.E. Stress-induced biological aging: A review and guide for research priorities. Brain Behav. Immun. 2022;104:97&#x2013;109. doi: 10.1016/j.bbi.2022.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.05.016</ArticleId><ArticleId IdType="pubmed">35661679</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunnane S.C., Trushina E., Morland C., Prigione A., Casadesus G., Andrews Z.B., Beal M.F., Bergersen L.H., Brinton R.D., de La Monte S., et al. Brain energy rescue: An emerging therapeutic concept for neurodegenerative disorders of ageing. Nat. Rev. Drug Discov. 2020;19:609&#x2013;633. doi: 10.1038/s41573-020-0072-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-020-0072-x</ArticleId><ArticleId IdType="pmc">PMC7948516</ArticleId><ArticleId IdType="pubmed">32709961</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandya V.A., Patani R. Decoding the relationship between ageing and amyotrophic lateral sclerosis: A cellular perspective. Brain. 2020;143:1057&#x2013;1072. doi: 10.1093/brain/awz360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz360</ArticleId><ArticleId IdType="pmc">PMC7174045</ArticleId><ArticleId IdType="pubmed">31851317</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono S., Imai T., Munakata S., Takahashi K., Kanda F., Hashimoto K., Yamano T., Shimizu N., Nagao K., Yamauchi M. Collagen abnormalities in the spinal cord from patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 1998;160:140&#x2013;147. doi: 10.1016/S0022-510X(98)00223-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(98)00223-8</ArticleId><ArticleId IdType="pubmed">9849796</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer I., Andr&#xe9;s-Benito P., Carmona M., Assialioui A., Povedano M. TDP-43 Vasculopathy in the Spinal Cord in Sporadic Amyotrophic Lateral Sclerosis (sALS) and Frontal Cortex in sALS/FTLD-TDP. J. Neuropathol. Exp. Neurol. 2021;80:229&#x2013;239. doi: 10.1093/jnen/nlaa162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlaa162</ArticleId><ArticleId IdType="pmc">PMC7899266</ArticleId><ArticleId IdType="pubmed">33421065</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamudio F., Loon A.R., Smeltzer S., Benyamine K., Navalpur Shanmugam N.K., Stewart N.J.F., Lee D.C., Nash K., Selenica M.-L.B. TDP-43 mediated blood-brain barrier permeability and leukocyte infiltration promote neurodegeneration in a low-grade systemic inflammation mouse model. J. Neuroinflammation. 2020;17:283. doi: 10.1186/s12974-020-01952-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01952-9</ArticleId><ArticleId IdType="pmc">PMC7519496</ArticleId><ArticleId IdType="pubmed">32979923</ArticleId></ArticleIdList></Reference><Reference><Citation>Crapser J.D., Spangenberg E.E., Barahona R.A., Arreola M.A., Hohsfield L.A., Green K.N. Microglia facilitate loss of perineuronal nets in the Alzheimer&#x2019;s disease brain. EBioMedicine. 2020;58:102919. doi: 10.1016/j.ebiom.2020.102919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102919</ArticleId><ArticleId IdType="pmc">PMC7399129</ArticleId><ArticleId IdType="pubmed">32745992</ArticleId></ArticleIdList></Reference><Reference><Citation>Tansley S., Gu N., Guzm&#xe1;n A.U., Cai W., Wong C., Lister K.C., Mu&#xf1;oz-Pino E., Yousefpour N., Roome R.B., Heal J., et al. Microglia-mediated degradation of perineuronal nets promotes pain. Science. 2022;377:80&#x2013;86. doi: 10.1126/science.abl6773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abl6773</ArticleId><ArticleId IdType="pubmed">35617374</ArticleId></ArticleIdList></Reference><Reference><Citation>Suttkus A., Rohn S., Weigel S., Gl&#xf6;ckner P., Arendt T., Morawski M. Aggrecan, link protein and tenascin-R are essential components of the perineuronal net to protect neurons against iron-induced oxidative stress. Cell Death Dis. 2014;5:e1119. doi: 10.1038/cddis.2014.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.25</ArticleId><ArticleId IdType="pmc">PMC3973247</ArticleId><ArticleId IdType="pubmed">24625978</ArticleId></ArticleIdList></Reference><Reference><Citation>Morawski M., Br&#xfc;ckner M.K., Riederer P., Br&#xfc;ckner G., Arendt T. Perineuronal nets potentially protect against oxidative stress. Exp. Neurol. 2004;188:309&#x2013;315. doi: 10.1016/j.expneurol.2004.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2004.04.017</ArticleId><ArticleId IdType="pubmed">15246831</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemarchant S., Pomeshchik Y., Kidin I., K&#xe4;rkk&#xe4;inen V., Valonen P., Lehtonen S., Goldsteins G., Malm T., Kanninen K., Koistinaho J. ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis. Mol. Neurodegener. 2016;11:10. doi: 10.1186/s13024-016-0078-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0078-3</ArticleId><ArticleId IdType="pmc">PMC4727317</ArticleId><ArticleId IdType="pubmed">26809777</ArticleId></ArticleIdList></Reference><Reference><Citation>Forostyak S., Forostyak O., Kwok J.C.F., Romanyuk N., Rehorova M., Kriska J., Dayanithi G., Raha-Chowdhury R., Jendelova P., Anderova M., et al. Transplantation of Neural Precursors Derived from Induced Pluripotent Cells Preserve Perineuronal Nets and Stimulate Neural Plasticity in ALS Rats. Int. J. Mol. Sci. 2020;21:9593. doi: 10.3390/ijms21249593.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21249593</ArticleId><ArticleId IdType="pmc">PMC7766921</ArticleId><ArticleId IdType="pubmed">33339362</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirian A., Moszczynski A., Soleimani S., Aubert I., Zinman L., Abrahao A. Breached Barriers: A Scoping Review of Blood-Central Nervous System Barrier Pathology in Amyotrophic Lateral Sclerosis. Front. Cell. Neurosci. 2022;16:851563. doi: 10.3389/fncel.2022.851563.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2022.851563</ArticleId><ArticleId IdType="pmc">PMC9009245</ArticleId><ArticleId IdType="pubmed">35431812</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney M.D., Zhao Z., Montagne A., Nelson A.R., Zlokovic B.V. Blood-Brain Barrier: From Physiology to Disease and Back. Physiol. Rev. 2019;99:21&#x2013;78. doi: 10.1152/physrev.00050.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00050.2017</ArticleId><ArticleId IdType="pmc">PMC6335099</ArticleId><ArticleId IdType="pubmed">30280653</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnenfeld H., Kascsak R.J., Bartfeld H. Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients. J. Neuroimmunol. 1984;6:51&#x2013;57. doi: 10.1016/0165-5728(84)90042-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-5728(84)90042-0</ArticleId><ArticleId IdType="pubmed">6368581</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Modo M. Advances in the application of MRI to amyotrophic lateral sclerosis. Expert Opin. Med. Diagn. 2010;4:483&#x2013;496. doi: 10.1517/17530059.2010.536836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/17530059.2010.536836</ArticleId><ArticleId IdType="pmc">PMC3080036</ArticleId><ArticleId IdType="pubmed">21516259</ArticleId></ArticleIdList></Reference><Reference><Citation>Grolez G., Moreau C., Danel-Brunaud V., Delmaire C., Lopes R., Pradat P.F., El Mendili M.M., Defebvre L., Devos D. The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: A systematic review. BMC Neurol. 2016;16:155. doi: 10.1186/s12883-016-0672-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-016-0672-6</ArticleId><ArticleId IdType="pmc">PMC5002331</ArticleId><ArticleId IdType="pubmed">27567641</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J.J. Cerebrovascular-Reactivity Mapping Using MRI: Considerations for Alzheimer&#x2019;s Disease. Front. Aging Neurosci. 2018;10:170. doi: 10.3389/fnagi.2018.00170.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00170</ArticleId><ArticleId IdType="pmc">PMC5996106</ArticleId><ArticleId IdType="pubmed">29922153</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagne A., Barnes S.R., Nation D.A., Kisler K., Toga A.W., Zlokovic B.V. Imaging subtle leaks in the blood-brain barrier in the aging human brain: Potential pitfalls, challenges, and possible solutions. Geroscience. 2022;44:1339&#x2013;1351. doi: 10.1007/s11357-022-00571-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-022-00571-x</ArticleId><ArticleId IdType="pmc">PMC9213625</ArticleId><ArticleId IdType="pubmed">35469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto J., Bright M.G., Bulte D.P., Figueiredo P. Cerebrovascular Reactivity Mapping Without Gas Challenges: A Methodological Guide. Front. Physiol. 2020;11:608475. doi: 10.3389/fphys.2020.608475.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.608475</ArticleId><ArticleId IdType="pmc">PMC7848198</ArticleId><ArticleId IdType="pubmed">33536935</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleight E., Stringer M.S., Marshall I., Wardlaw J.M., Thrippleton M.J. Cerebrovascular Reactivity Measurement Using Magnetic Resonance Imaging: A Systematic Review. Front. Physiol. 2021;12:643468. doi: 10.3389/fphys.2021.643468.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.643468</ArticleId><ArticleId IdType="pmc">PMC7947694</ArticleId><ArticleId IdType="pubmed">33716793</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M.Y., Woodward A., Fan A.P., Chen K.T., Yu Y., Chen D.Y., Moseley M.E., Zaharchuk G. Reproducibility of cerebrovascular reactivity measurements: A systematic review of neuroimaging techniques. J. Cereb. Blood Flow Metab. 2022;42:700&#x2013;717. doi: 10.1177/0271678X211056702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X211056702</ArticleId><ArticleId IdType="pmc">PMC9254040</ArticleId><ArticleId IdType="pubmed">34806918</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickie B.R., Parker G.J.M., Parkes L.M. Measuring water exchange across the blood-brain barrier using MRI. Prog. Nucl. Magn. Reson. Spectrosc. 2020;116:19&#x2013;39. doi: 10.1016/j.pnmrs.2019.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnmrs.2019.09.002</ArticleId><ArticleId IdType="pubmed">32130957</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann K., G&#xfc;nther M., D&#xfc;zel E., Schreiber S. Microvascular Impairment in Patients With Cerebral Small Vessel Disease Assessed With Arterial Spin Labeling Magnetic Resonance Imaging: A Pilot Study. Front. Aging Neurosci. 2022;14:871612. doi: 10.3389/fnagi.2022.871612.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.871612</ArticleId><ArticleId IdType="pmc">PMC9161030</ArticleId><ArticleId IdType="pubmed">35663571</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph C.R., Benhatzel C.M., Stern L.J., Hopper O.M., Lockwood M.D. Pilot study utilizing MRI 3D TGSE PASL (arterial spin labeling) differentiating clearance rates of labeled protons in the CNS of patients with early Alzheimer disease from normal subjects. MAGMA. 2020;33:559&#x2013;568. doi: 10.1007/s10334-019-00818-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10334-019-00818-3</ArticleId><ArticleId IdType="pubmed">31897905</ArticleId></ArticleIdList></Reference><Reference><Citation>Absinta M., Ha S.-K., Nair G., Sati P., Luciano N.J., Palisoc M., Louveau A., Zaghloul K.A., Pittaluga S., Kipnis J., et al. Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI. Elife. 2017;6:e29738. doi: 10.7554/eLife.29738.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.29738</ArticleId><ArticleId IdType="pmc">PMC5626482</ArticleId><ArticleId IdType="pubmed">28971799</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris A.W.J., Sharp M.M., Albargothy N.J., Fernandes R., Hawkes C.A., Verma A., Weller R.O., Carare R.O. Vascular basement membranes as pathways for the passage of fluid into and out of the brain. Acta Neuropathol. 2016;131:725&#x2013;736. doi: 10.1007/s00401-016-1555-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1555-z</ArticleId><ArticleId IdType="pmc">PMC4835509</ArticleId><ArticleId IdType="pubmed">26975356</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldea R., Weller R.O., Wilcock D.M., Carare R.O., Richardson G. Cerebrovascular Smooth Muscle Cells as the Drivers of Intramural Periarterial Drainage of the Brain. Front. Aging Neurosci. 2019;11:1. doi: 10.3389/fnagi.2019.00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2019.00001</ArticleId><ArticleId IdType="pmc">PMC6357927</ArticleId><ArticleId IdType="pubmed">30740048</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringstad G., Eide P.K. Cerebrospinal fluid tracer efflux to parasagittal dura in humans. Nat. Commun. 2020;11:354. doi: 10.1038/s41467-019-14195-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-14195-x</ArticleId><ArticleId IdType="pmc">PMC6969040</ArticleId><ArticleId IdType="pubmed">31953399</ArticleId></ArticleIdList></Reference><Reference><Citation>Taoka T., Naganawa S. Glymphatic imaging using MRI. J. Magn. Reson. Imaging. 2020;51:11&#x2013;24. doi: 10.1002/jmri.26892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.26892</ArticleId><ArticleId IdType="pubmed">31423710</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsop D.C., Detre J.A., Golay X., G&#xfc;nther M., Hendrikse J., Hernandez-Garcia L., Lu H., MacIntosh B.J., Parkes L.M., Smits M., et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn. Reson. Med. 2015;73:102&#x2013;116. doi: 10.1002/mrm.25197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.25197</ArticleId><ArticleId IdType="pmc">PMC4190138</ArticleId><ArticleId IdType="pubmed">24715426</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney M.D., Kisler K., Montagne A., Toga A.W., Zlokovic B.V. The role of brain vasculature in neurodegenerative disorders. Nat. Neurosci. 2018;21:1318&#x2013;1331. doi: 10.1038/s41593-018-0234-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0234-x</ArticleId><ArticleId IdType="pmc">PMC6198802</ArticleId><ArticleId IdType="pubmed">30250261</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Y., Abrahao A., Heyn C.C., Bethune A.J., Huang Y., Pople C.B., Aubert I., Hamani C., Zinman L., Hynynen K., et al. Glymphatics Visualization after Focused Ultrasound-Induced Blood-Brain Barrier Opening in Humans. Ann. Neurol. 2019;86:975&#x2013;980. doi: 10.1002/ana.25604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25604</ArticleId><ArticleId IdType="pubmed">31525269</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.-H., Lirng J.-F., Ling Y.-H., Wang Y.-F., Wu H.-M., Fuh J.-L., Lin P.-C., Wang S.-J., Chen S.-P. Noninvasive Characterization of Human Glymphatics and Meningeal Lymphatics in an in vivo Model of Blood-Brain Barrier Leakage. Ann. Neurol. 2021;89:111&#x2013;124. doi: 10.1002/ana.25928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25928</ArticleId><ArticleId IdType="pubmed">33030257</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber S., John A.-C., Werner C.J., Vielhaber S., Heinze H.-J., Speck O., W&#xfc;rfel J., Behme D., Mattern H. Counteraction of inflammatory activity in CAA-related subarachnoid hemorrhage. J. Neurol. 2022;270:1159&#x2013;1161. doi: 10.1007/s00415-022-11437-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11437-9</ArticleId><ArticleId IdType="pmc">PMC9886617</ArticleId><ArticleId IdType="pubmed">36308530</ArticleId></ArticleIdList></Reference><Reference><Citation>Eide P.K., Vatnehol S.A.S., Emblem K.E., Ringstad G. Magnetic resonance imaging provides evidence of glymphatic drainage from human brain to cervical lymph nodes. Sci. Rep. 2018;8:7194. doi: 10.1038/s41598-018-25666-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25666-4</ArticleId><ArticleId IdType="pmc">PMC5940793</ArticleId><ArticleId IdType="pubmed">29740121</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardlaw J.M., Benveniste H., Nedergaard M., Zlokovic B.V., Mestre H., Lee H., Doubal F.N., Brown R., Ramirez J., MacIntosh B.J., et al. Perivascular spaces in the brain: Anatomy, physiology and pathology. Nat. Rev. Neurol. 2020;16:137&#x2013;153. doi: 10.1038/s41582-020-0312-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0312-z</ArticleId><ArticleId IdType="pubmed">32094487</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischl B., van der Kouwe A., Destrieux C., Halgren E., S&#xe9;gonne F., Salat D.H., Busa E., Seidman L.J., Goldstein J., Kennedy D., et al. Automatically parcellating the human cerebral cortex. Cereb. Cortex. 2004;14:11&#x2013;22. doi: 10.1093/cercor/bhg087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhg087</ArticleId><ArticleId IdType="pubmed">14654453</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Brady M., Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans. Med. Imaging. 2001;20:45&#x2013;57. doi: 10.1109/42.906424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/42.906424</ArticleId><ArticleId IdType="pubmed">11293691</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernal J., Vald&#xe9;s-Hern&#xe1;ndez M.D.C., Escudero J., Duarte R., Ballerini L., Bastin M.E., Deary I.J., Thrippleton M.J., Touyz R.M., Wardlaw J.M. Assessment of perivascular space filtering methods using a three-dimensional computational model. Magn. Reson. Imaging. 2022;93:33&#x2013;51. doi: 10.1016/j.mri.2022.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mri.2022.07.016</ArticleId><ArticleId IdType="pubmed">35932975</ArticleId></ArticleIdList></Reference><Reference><Citation>Bollmann S., Mattern H., Bernier M., Robinson S.D., Park D., Speck O., Polimeni J.R. Imaging of the pial arterial vasculature of the human brain in vivo using high-resolution 7T time-of-flight angiography. Elife. 2022;11:e71186. doi: 10.7554/eLife.71186.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.71186</ArticleId><ArticleId IdType="pmc">PMC9150892</ArticleId><ArticleId IdType="pubmed">35486089</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattern H., Sciarra A., Godenschweger F., Stucht D., L&#xfc;sebrink F., Rose G., Speck O. Prospective motion correction enables highest resolution time-of-flight angiography at 7T. Magn. Reson. Med. 2018;80:248&#x2013;258. doi: 10.1002/mrm.27033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.27033</ArticleId><ArticleId IdType="pmc">PMC5876090</ArticleId><ArticleId IdType="pubmed">29230871</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang C.-K., Park C.-A., Park C.-W., Lee Y.-B., Cho Z.-H., Kim Y.-B. Lenticulostriate arteries in chronic stroke patients visualised by 7 T magnetic resonance angiography. Int. J. Stroke. 2010;5:374&#x2013;380. doi: 10.1111/j.1747-4949.2010.00464.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1747-4949.2010.00464.x</ArticleId><ArticleId IdType="pubmed">20854620</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrikse J., Zwanenburg J.J., Visser F., Takahara T., Luijten P. Noninvasive depiction of the lenticulostriate arteries with time-of-flight MR angiography at 7.0 T. Cerebrovasc. Dis. 2008;26:624&#x2013;629. doi: 10.1159/000166838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000166838</ArticleId><ArticleId IdType="pubmed">18984947</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohmann R., Speck O., Scheffler K. Signal-to-noise ratio and MR tissue parameters in human brain imaging at 3, 7, and 9.4 tesla using current receive coil arrays. Magn. Reson. Med. 2016;75:801&#x2013;809. doi: 10.1002/mrm.25677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.25677</ArticleId><ArticleId IdType="pubmed">25820458</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xfc;sebrink F., Mattern H., Yakupov R., Acosta-Cabronero J., Ashtarayeh M., Oeltze-Jafra S., Speck O. Comprehensive ultrahigh resolution whole brain in vivo MRI dataset as a human phantom. Sci. Data. 2021;8:138. doi: 10.1038/s41597-021-00923-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41597-021-00923-w</ArticleId><ArticleId IdType="pmc">PMC8149725</ArticleId><ArticleId IdType="pubmed">34035308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladd M.E., Bachert P., Meyerspeer M., Moser E., Nagel A.M., Norris D.G., Schmitter S., Speck O., Straub S., Zaiss M. Pros and cons of ultra-high-field MRI/MRS for human application. Prog. Nucl. Magn. Reson. Spectrosc. 2018;109:1&#x2013;50. doi: 10.1016/j.pnmrs.2018.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnmrs.2018.06.001</ArticleId><ArticleId IdType="pubmed">30527132</ArticleId></ArticleIdList></Reference><Reference><Citation>Feekes J.A., Hsu S.-W., Chaloupka J.C., Cassell M.D. Tertiary microvascular territories define lacunar infarcts in the basal ganglia. Ann. Neurol. 2005;58:18&#x2013;30. doi: 10.1002/ana.20505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20505</ArticleId><ArticleId IdType="pubmed">15900563</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrikse J., Petersen E.T., Chng S.M., Venketasubramanian N., Golay X. Distribution of cerebral blood flow in the nucleus caudatus, nucleus lentiformis, and thalamus: A study of territorial arterial spin-labeling MR imaging. Radiology. 2010;254:867&#x2013;875. doi: 10.1148/radiol.09090284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.09090284</ArticleId><ArticleId IdType="pubmed">20089720</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Garcia B., Mattern H., Vockert N., Yakupov R., Schreiber F., Spallazzi M., Perosa V., Speck O., Duzel E., Maass A., et al. Vessel distance mapping: A novel methodology for assessing vascular-induced cognitive resilience. Alzheimer Dement. 2022;18:e063391. doi: 10.1002/alz.063391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.063391</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattern H., Speck O. ESMRMB 2020 Online, 37th Annual Scientific Meeting, 30 September&#x2013;2 October: Lightning Talks/Electronic Posters/Clinical ReviewPosters/Software Exhibits. Magn. Reson. Mater. Phys. Biol. Med. 2020;33:69&#x2013;233. doi: 10.1007/s10334-020-00876-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10334-020-00876-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattern H., Schreiber S., Speck O. Vessel distance mapping for deep gray matter structures. Proc. Intl. Soc. Mag. Reson. Med. Virtual Meet. ISMRM. 2021</Citation></Reference><Reference><Citation>Lam C.K., Yoo T., Hiner B., Liu Z., Grutzendler J. Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization. Nature. 2010;465:478&#x2013;482. doi: 10.1038/nature09001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09001</ArticleId><ArticleId IdType="pmc">PMC2879083</ArticleId><ArticleId IdType="pubmed">20505729</ArticleId></ArticleIdList></Reference><Reference><Citation>Sances S., Ho R., Vatine G., West D., Laperle A., Meyer A., Godoy M., Kay P.S., Mandefro B., Hatata S., et al. Human iPSC-Derived Endothelial Cells and Microengineered Organ-Chip Enhance Neuronal Development. Stem Cell Rep. 2018;10:1222&#x2013;1236. doi: 10.1016/j.stemcr.2018.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2018.02.012</ArticleId><ArticleId IdType="pmc">PMC5998748</ArticleId><ArticleId IdType="pubmed">29576540</ArticleId></ArticleIdList></Reference><Reference><Citation>Warburton D.E.R., Nicol C.W., Bredin S.S.D. Health benefits of physical activity: The evidence. CMAJ. 2006;174:801&#x2013;809. doi: 10.1503/cmaj.051351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.051351</ArticleId><ArticleId IdType="pmc">PMC1402378</ArticleId><ArticleId IdType="pubmed">16534088</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsitkanou S., Della Gatta P., Foletta V., Russell A. The Role of Exercise as a Non-pharmacological Therapeutic Approach for Amyotrophic Lateral Sclerosis: Beneficial or Detrimental? Front. Neurol. 2019;10:783. doi: 10.3389/fneur.2019.00783.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00783</ArticleId><ArticleId IdType="pmc">PMC6652799</ArticleId><ArticleId IdType="pubmed">31379732</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal Bello-Haas V., Florence J.M. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst. Rev. 2013;2013:CD005229. doi: 10.1002/14651858.CD005229.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD005229.pub3</ArticleId><ArticleId IdType="pmc">PMC6769061</ArticleId><ArticleId IdType="pubmed">23728653</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller P. Physical Activity and Sports in the Prevention and Therapy of Neurodegenerative Diseases. Dtsch Z Sportmed. 2020;71:113&#x2013;116. doi: 10.5960/dzsm.2020.418.</Citation><ArticleIdList><ArticleId IdType="doi">10.5960/dzsm.2020.418</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Benzi G., Dossena M., Mutani R., Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005;128:472&#x2013;476. doi: 10.1093/brain/awh373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh373</ArticleId><ArticleId IdType="pubmed">15634730</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehman E.J., Hein M.J., Baron S.L., Gersic C.M. Neurodegenerative causes of death among retired National Football League players. Neurology. 2012;79:1970&#x2013;1974. doi: 10.1212/WNL.0b013e31826daf50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31826daf50</ArticleId><ArticleId IdType="pmc">PMC4098841</ArticleId><ArticleId IdType="pubmed">22955124</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupillo E., Messina P., Giussani G., Logroscino G., Zoccolella S., Chi&#xf2; A., Calvo A., Corbo M., Lunetta C., Marin B., et al. Physical activity and amyotrophic lateral sclerosis: A European population-based case-control study. Ann. Neurol. 2014;75:708&#x2013;716. doi: 10.1002/ana.24150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24150</ArticleId><ArticleId IdType="pubmed">24706338</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xfc;gel M., Weydt P. Sports and Physical Activity in Patients Suffering from Rare Neurodegenerative Diseases: How Much is too Much, how Much is too Little? Dtsch Z Sportmed. 2015;2015:300&#x2013;307. doi: 10.5960/dzsm.2015.206.</Citation><ArticleIdList><ArticleId IdType="doi">10.5960/dzsm.2015.206</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L., Li X., Li C., Tsang R.C.C., Chen Y., Ge Y., Gao Q. Effects of Exercise in Patients With Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. Am. J. Phys. Med. Rehabil. 2020;99:801&#x2013;810. doi: 10.1097/PHM.0000000000001419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001419</ArticleId><ArticleId IdType="pubmed">32452880</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow L.S., Gerszten R.E., Taylor J.M., Pedersen B.K., van Praag H., Trappe S., Febbraio M.A., Galis Z.S., Gao Y., Haus J.M., et al. Exerkines in health, resilience and disease. Nat. Rev. Endocrinol. 2022;18:273&#x2013;289. doi: 10.1038/s41574-022-00641-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00641-2</ArticleId><ArticleId IdType="pmc">PMC9554896</ArticleId><ArticleId IdType="pubmed">35304603</ArticleId></ArticleIdList></Reference><Reference><Citation>Kam T.-I., Park H., Chou S.-C., van Vranken J.G., Mittenb&#xfc;hler M.J., Kim H., Choi Y.R., Biswas D., Wang J., Shin Y., et al. Amelioration of pathologic &#x3b1;-synuclein-induced Parkinson&#x2019;s disease by irisin. Proc. Natl. Acad. Sci. USA. 2022;119:e2204835119. doi: 10.1073/pnas.2204835119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2204835119</ArticleId><ArticleId IdType="pmc">PMC9457183</ArticleId><ArticleId IdType="pubmed">36044549</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P., Liu L., Yang X., Li M., Zhao Q., Wu H. Irisin improves BBB dysfunction in SAP rats by inhibiting MMP-9 via the ERK/NF-&#x3ba;B signaling pathway. Cell. Signal. 2022;93:110300. doi: 10.1016/j.cellsig.2022.110300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2022.110300</ArticleId><ArticleId IdType="pubmed">35259454</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Tian M., Tan J., Pei X., Lu C., Xin Y., Deng S., Zhao F., Gao Y., Gong Y. Irisin ameliorates neuroinflammation and neuronal apoptosis through integrin &#x3b1;V&#x3b2;5/AMPK signaling pathway after intracerebral hemorrhage in mice. J. Neuroinflamm. 2022;19:82. doi: 10.1186/s12974-022-02438-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02438-6</ArticleId><ArticleId IdType="pmc">PMC8988353</ArticleId><ArticleId IdType="pubmed">35392928</ArticleId></ArticleIdList></Reference><Reference><Citation>Lourenco M.V., Frozza R.L., de Freitas G.B., Zhang H., Kincheski G.C., Ribeiro F.C., Gon&#xe7;alves R.A., Clarke J.R., Beckman D., Staniszewski A., et al. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer&#x2019;s models. Nat. Med. 2019;25:165&#x2013;175. doi: 10.1038/s41591-018-0275-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0275-4</ArticleId><ArticleId IdType="pmc">PMC6327967</ArticleId><ArticleId IdType="pubmed">30617325</ArticleId></ArticleIdList></Reference><Reference><Citation>Casaletto K.B., Lindbergh C.A., VandeBunte A., Neuhaus J., Schneider J.A., Buchman A.S., Honer W.G., Bennett D.A. Microglial Correlates of Late Life Physical Activity: Relationship with Synaptic and Cognitive Aging in Older Adults. J. Neurosci. 2022;42:288&#x2013;298. doi: 10.1523/JNEUROSCI.1483-21.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1483-21.2021</ArticleId><ArticleId IdType="pmc">PMC8802938</ArticleId><ArticleId IdType="pubmed">34810231</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam M.R., Valaris S., Young M.F., Haley E.B., Luo R., Bond S.F., Mazuera S., Kitchen R.R., Caldarone B.J., Bettio L.E.B., et al. Exercise hormone irisin is a critical regulator of cognitive function. Nat. Metab. 2021;3:1058&#x2013;1070. doi: 10.1038/s42255-021-00438-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00438-z</ArticleId><ArticleId IdType="pubmed">34417591</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Xu Y., Xuan R., Huang J., Istv&#xe1;n B., Fekete G., Gu Y. Mixed Comparison of Different Exercise Interventions for Function, Respiratory, Fatigue, and Quality of Life in Adults With Amyotrophic Lateral Sclerosis: Systematic Review and Network Meta-Analysis. Front. Aging Neurosci. 2022;14:919059. doi: 10.3389/fnagi.2022.919059.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.919059</ArticleId><ArticleId IdType="pmc">PMC9309467</ArticleId><ArticleId IdType="pubmed">35898325</ArticleId></ArticleIdList></Reference><Reference><Citation>Keifer O.P., O&#x2019;Connor D.M., Boulis N.M. Gene and protein therapies utilizing VEGF for ALS. Pharmacol. Ther. 2014;141:261&#x2013;271. doi: 10.1016/j.pharmthera.2013.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2013.10.009</ArticleId><ArticleId IdType="pmc">PMC4659499</ArticleId><ArticleId IdType="pubmed">24177067</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Chen Y., Feng W., Cai J., Gao J., Ge F., Zhou T., Wang Z., Ding F., Marshall C., et al. Drainage of senescent astrocytes from brain via meningeal lymphatic routes. Brain Behav. Immun. 2022;103:85&#x2013;96. doi: 10.1016/j.bbi.2022.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.005</ArticleId><ArticleId IdType="pubmed">35427759</ArticleId></ArticleIdList></Reference><Reference><Citation>Berthiaume A.-A., Schmid F., Stamenkovic S., Coelho-Santos V., Nielson C.D., Weber B., Majesky M.W., Shih A.Y. Pericyte remodeling is deficient in the aged brain and contributes to impaired capillary flow and structure. Nat. Commun. 2022;13:5912. doi: 10.1038/s41467-022-33464-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33464-w</ArticleId><ArticleId IdType="pmc">PMC9547063</ArticleId><ArticleId IdType="pubmed">36207315</ArticleId></ArticleIdList></Reference><Reference><Citation>Omote Y., Deguchi K., Kono S., Liu N., Liu W., Kurata T., Yamashita T., Ikeda Y., Abe K. Neurovascular protection of cilostazol in stroke-prone spontaneous hypertensive rats associated with angiogenesis and pericyte proliferation. J. Neurosci. Res. 2014;92:369&#x2013;374. doi: 10.1002/jnr.23327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23327</ArticleId><ArticleId IdType="pubmed">24375726</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.N., Kim T.-Y., Yoon Y.H., Koh J.-Y. Pyruvate and cilostazol protect cultured rat cortical pericytes against tissue plasminogen activator (tPA)-induced cell death. Brain Res. 2015;1628:317&#x2013;326. doi: 10.1016/j.brainres.2015.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2015.06.022</ArticleId><ArticleId IdType="pubmed">26111647</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul G., Zachrisson O., Varrone A., Almqvist P., Jerling M., Lind G., Rehncrona S., Linderoth B., Bjartmarz H., Shafer L.L., et al. Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson&#x2019;s disease patients. J. Clin. Invest. 2015;125:1339&#x2013;1346. doi: 10.1172/JCI79635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI79635</ArticleId><ArticleId IdType="pmc">PMC4362250</ArticleId><ArticleId IdType="pubmed">25689258</ArticleId></ArticleIdList></Reference><Reference><Citation>Procter T.V., Williams A., Montagne A. Interplay between Brain Pericytes and Endothelial Cells in Dementia. Am. J. Pathol. 2021;191:1917&#x2013;1931. doi: 10.1016/j.ajpath.2021.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2021.07.003</ArticleId><ArticleId IdType="pubmed">34329605</ArticleId></ArticleIdList></Reference><Reference><Citation>Maximova A., Werry E.L., Kassiou M. Senolytics: A Novel Strategy for Neuroprotection in ALS? Int. J. Mol. Sci. 2021;22:12078. doi: 10.3390/ijms222112078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222112078</ArticleId><ArticleId IdType="pmc">PMC8584291</ArticleId><ArticleId IdType="pubmed">34769512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ya J., Kadir R.R.A., Bayraktutan U. Delay of endothelial cell senescence protects cerebral barrier against age-related dysfunction: Role of senolytics and senomorphics. Tissue Barriers. 2022:2103353. doi: 10.1080/21688370.2022.2103353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21688370.2022.2103353</ArticleId><ArticleId IdType="pubmed">35880392</ArticleId></ArticleIdList></Reference><Reference><Citation>Monsour M., Garbuzova-Davis S., Borlongan C.V. Patching Up the Permeability: The Role of Stem Cells in Lessening Neurovascular Damage in Amyotrophic Lateral Sclerosis. Stem Cells Transl. Med. 2022;11:1196&#x2013;1209. doi: 10.1093/stcltm/szac072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/stcltm/szac072</ArticleId><ArticleId IdType="pmc">PMC9801306</ArticleId><ArticleId IdType="pubmed">36181767</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadanandan N., Lee J.-Y., Garbuzova-Davis S. Extracellular vesicle-based therapy for amyotrophic lateral sclerosis. Brain Circ. 2021;7:23&#x2013;28. doi: 10.4103/bc.bc_9_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/bc.bc_9_21</ArticleId><ArticleId IdType="pmc">PMC8057104</ArticleId><ArticleId IdType="pubmed">34084973</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L., Gelati M., Profico D.C., Sorar&#xf9; G., Ferrari D., Copetti M., Muzi G., Ricciolini C., Carletti S., Giorgi C., et al. Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome. Stem Cells Transl. Med. 2019;8:887&#x2013;897. doi: 10.1002/sctm.18-0154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sctm.18-0154</ArticleId><ArticleId IdType="pmc">PMC6708070</ArticleId><ArticleId IdType="pubmed">31104357</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahao A., Meng Y., Llinas M., Huang Y., Hamani C., Mainprize T., Aubert I., Heyn C., Black S.E., Hynynen K., et al. First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound. Nat. Commun. 2019;10:4373. doi: 10.1038/s41467-019-12426-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12426-9</ArticleId><ArticleId IdType="pmc">PMC6763482</ArticleId><ArticleId IdType="pubmed">31558719</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzas E.I., Gy&#xf6;rgy B., Nagy G., Falus A., Gay S. Emerging role of extracellular vesicles in inflammatory diseases. Nat. Rev. Rheumatol. 2014;10:356&#x2013;364. doi: 10.1038/nrrheum.2014.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2014.19</ArticleId><ArticleId IdType="pubmed">24535546</ArticleId></ArticleIdList></Reference><Reference><Citation>Laffont B., Corduan A., Pl&#xe9; H., Duchez A.-C., Cloutier N., Boilard E., Provost P. Activated platelets can deliver mRNA regulatory Ago2&#x2022;microRNA complexes to endothelial cells via microparticles. Blood. 2013;122:253&#x2013;261. doi: 10.1182/blood-2013-03-492801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2013-03-492801</ArticleId><ArticleId IdType="pubmed">23652806</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Talbot K., McDermott C.J., Hardiman O., Shefner J.M., Al-Chalabi A., Huynh W., Cudkowicz M., Talman P., et al. Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2021;17:104&#x2013;118. doi: 10.1038/s41582-020-00434-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00434-z</ArticleId><ArticleId IdType="pmc">PMC7747476</ArticleId><ArticleId IdType="pubmed">33340024</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallego I., Villate-Beitia I., Saenz-Del-Burgo L., Puras G., Pedraz J.L. Therapeutic Opportunities and Delivery Strategies for Brain Revascularization in Stroke, Neurodegeneration, and Aging. Pharmacol. Rev. 2022;74:439&#x2013;461. doi: 10.1124/pharmrev.121.000418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pharmrev.121.000418</ArticleId><ArticleId IdType="pubmed">35302047</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnett D.K., Blumenthal R.S., Albert M.A., Buroker A.B., Goldberger Z.D., Hahn E.J., Himmelfarb C.D., Khera A., Lloyd-Jones D., McEvoy J.W., et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596&#x2013;e646. doi: 10.1161/CIR.0000000000000678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000678</ArticleId><ArticleId IdType="pmc">PMC7734661</ArticleId><ArticleId IdType="pubmed">30879355</ArticleId></ArticleIdList></Reference><Reference><Citation>Visseren F.L.J., Mach F., Smulders Y.M., Carballo D., Koskinas K.C., B&#xe4;ck M., Benetos A., Biffi A., Boavida J.-M., Capodanno D., et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2021;42:3227&#x2013;3337. doi: 10.1093/eurheartj/ehab484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab484</ArticleId><ArticleId IdType="pubmed">34458905</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J.T., Williamson J.D., Whelton P.K., Snyder J.K., Sink K.M., Rocco M.V., Reboussin D.M., Rahman M., Oparil S., Lewis C.E., et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N. Engl. J. Med. 2015;373:2103&#x2013;2116. doi: 10.1056/NEJMoa1511939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1511939</ArticleId><ArticleId IdType="pmc">PMC4689591</ArticleId><ArticleId IdType="pubmed">26551272</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson J.D., Pajewski N.M., Auchus A.P., Bryan R.N., Chelune G., Cheung A.K., Cleveland M.L., Coker L.H., Crowe M.G., Cushman W.C., et al. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA. 2019;321:553&#x2013;561. doi: 10.1001/jama.2018.21442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.21442</ArticleId><ArticleId IdType="pmc">PMC6439590</ArticleId><ArticleId IdType="pubmed">30688979</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiappelli J., Adhikari B.M., Kvarta M.D., Bruce H.A., Goldwaser E.L., Ma Y., Chen S., Ament S., Shuldiner A.R., Mitchell B.D., et al. Depression, stress, and regional cerebral blood flow. J. Cereb. Blood Flow Metab. 2023:271678X221148979. doi: 10.1177/0271678X221148979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X221148979</ArticleId><ArticleId IdType="pubmed">36606600</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann M.L., Poffenberger C.N., Elkahloun A.G., Herkenham M. Analysis of cerebrovascular dysfunction caused by chronic social defeat in mice. Brain Behav. Immun. 2020;88:735&#x2013;747. doi: 10.1016/j.bbi.2020.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.030</ArticleId><ArticleId IdType="pmc">PMC7416466</ArticleId><ArticleId IdType="pubmed">32413560</ArticleId></ArticleIdList></Reference><Reference><Citation>Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L., Cooney M.-T., Corr&#xe0; U., Cosyns B., Deaton C., et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR) Eur. Heart J. 2016;37:2315&#x2013;2381. doi: 10.1093/eurheartj/ehw106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehw106</ArticleId><ArticleId IdType="pmc">PMC4986030</ArticleId><ArticleId IdType="pubmed">27222591</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson K., Murphy A., McDonnell E., Shapiro J., Simpson E., Glass J., Mitsumoto H., Forshew D., Miller R., Atassi N. Improving symptom management for people with amyotrophic lateral sclerosis. Muscle Nerve. 2018;57:20&#x2013;24. doi: 10.1002/mus.25712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25712</ArticleId><ArticleId IdType="pubmed">28561886</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidari M.E., Nadali J., Parouhan A., Azarafraz M., Tabatabai S.M., Irvani S.S.N., Eskandari F., Gharebaghi A. Prevalence of depression among amyotrophic lateral sclerosis (ALS) patients: A systematic review and meta-analysis. J. Affect. Disord. 2021;287:182&#x2013;190. doi: 10.1016/j.jad.2021.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.03.015</ArticleId><ArticleId IdType="pubmed">33799036</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein L.H., Atkins L., Landau S., Brown R.G., Leigh P.N. Longitudinal predictors of psychological distress and self-esteem in people with ALS. Neurology. 2006;67:1652&#x2013;1658. doi: 10.1212/01.wnl.0000242886.91786.47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000242886.91786.47</ArticleId><ArticleId IdType="pubmed">17101899</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Moglia C., Canosa A., Manera U., Vasta R., Brunetti M., Barberis M., Corrado L., D&#x2019;Alfonso S., Bersano E., et al. Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology. 2019;93:e984&#x2013;e994. doi: 10.1212/WNL.0000000000008063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008063</ArticleId><ArticleId IdType="pmc">PMC6745732</ArticleId><ArticleId IdType="pubmed">31409738</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould R.L., Thompson B.J., Rawlinson C., Kumar P., White D., Serfaty M.A., Graham C.D., McCracken L.M., Bursnall M., Bradburn M., et al. A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): Study protocol. BMC Neurol. 2022;22:431. doi: 10.1186/s12883-022-02950-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-022-02950-5</ArticleId><ArticleId IdType="pmc">PMC9664029</ArticleId><ArticleId IdType="pubmed">36380299</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>